Hybrid imaging: PET/MR climbs the diagnostic ladder
Experts across Europe believe the combination is beginning to demonstrate its broad potential as a hybrid imaging tool
PET/CT
In their infancy but new PET tracers have a rich future
Dr Peter Choyke, Chief of the Molecular Imaging Programme at the National Cancer Institute in Bethesda, USA, believes that new tracers will have an evolving role to play and represent an exciting development in the imaging of cancers.
Future radiology infrastructures
When asked about his vision of imaging in the year 2020, Professor Bernd Hamm MD, director of the three radiology clinics at the Charité University Hospital in Berlin, qualified his focus: ‘Technology is always only a vehicle. When we talk about road traffic, we don’t talk about the design of cars but about structural issues’
Hybrid imaging: Virtual FDG-PET/CT bronchoscopy
Virtual FDG-PET/CT bronchoscopy has been found to be a technically feasible tool for the detection of lymph node metastases in non-small cell lung cancer patients with good diagnostic accuracy, according to researchers at the Department of Diagnostic and Interventional Radiology, University Hospital Dusseldorf and Essen.
RADbook 2012 on your iPad
Quick, simple and comfortable – the RADbook 2012 on your iPad. Download the RADbook app free of charge today and have all state-of-the-art diagnostic imaging systems at your fingertips.
Hybrid imaging: PET-CT and MR-PET
A series of papers presented at the European Congress of Radiology on Friday have highlighted how hybrid imaging is helping radiologists achieve better results in the diagnosis of patients’ conditions. In a session focussing on molecular imaging and entitled “Hybrid imaging: PET-CT and MR-PET”, findings from ten different research papers were detailed by radiologists from Italy,…
What’ s new in the world of radiology?
Radiology constantly evolves. There are technical advances in terms of the capabilities of various modalities, greater clarity from contrast agents that are also safer for patients, and innovation in techniques that gains even greater performance from existing equipment, or enables further development.
What´s new in neuroradiology and interventional radiology?
When scanning seizures, Dr Walter Kucharczyk, director of MRI at Toronto General Hospital, believes that MRI still remains the best imaging test to discover if there is an anatomic or structural abnormality that might account for a seizure.
All in one: Hybrid imaging with MR/PET
Although like a conventional MR scanner the unassuming exterior is misleading. The casing houses a powerful interior. This is the new Siemens Biograph mMR, a hybrid that contains a specially developed PET component fully protected against magnetic field interference.
Assessing potential benefits in PET/MRI examination
In recent years, combined examination methods have increased, whereby two examination methods are used in a parallel examination, rather than performed separately. Frederik Giesel MD, Associate Professor of Radiology at the Nuclear Medicine Department, University of Heidelberg, and Philip Herold (Dipl. Econ.), Project Manager at RICT Heidelberg, report on the benefits.
GE Healthcare to Invest $1 Billion in New Oncology Solutions
GE Healthcare announced today its plans to dedicate $1 billion of its total R&D budget over the next five years to expand its advanced cancer diagnostic and molecular imaging capabilities, as well as its world-class technologies for the manufacture of biopharmaceuticals and for cancer research.
CT, PET-CT, MRT and transthoracic ultrasound in lung cancer staging
Dr Helmut Prosch, at the University Clinic for Radio-Diagnostics, Vienna, Austria, is examining the role of imaging in lung cancer diagnosis and staging. The key message of his presentation in the session EUS and EBUS vs. CT, MR and PET-CT in the staging of lung cancer is that the modalities do not compete with one another – as the title suggests – but are perfectly complimentary in the…
31st German Senology Congress - More opportunities in breast diagnostics
Yes, it’s in beautiful Dresden again and -- as in 2006 when the city last hosted the Congress of the German Society for Senology -- this year’s Congress President is Professor Rüdiger Schulz-Wendtland (Department of Radiology, University of Erlangen). However, the repetition ends there; the congress topics will be anything but repeated. Report: Meike Lerner
Molecular Imaging for Alzheimer’s Disease May Be Available in Hospitals Within One Year
Researchers the world over are advancing positron emission tomography (PET) as an effective method of early detection for Alzheimer’s disease, a currently incurable and deadly neurological disorder. Three studies presented at SNM’s 58th Annual Meeting are providing new insights into the development of Alzheimer’s disease while opening the door to future clinical screening and treatments.
Radiology & nuclear medicine - Sharing an awkward waltz in Vienna
CT-PET is the child of a forced marriage between nuclear medicine and radiology. A shared session at ECR 2011 in Vienna did little to assure there is a growing consensus between the two partners.
Contrast enhanced tumour studies
Medical imaging has recently advanced so rapidly that it should halt. Applying more power to computed tomography (CT) and magnetic resonance imaging (MRI) scanners is becoming too dangerous for patients and healthcare workers. Magnets for the next-generation MRIs are so powerful that they must be moved to a separate building on hospital campuses, while CT radiation levels have risen to alarming…
Bayer to Present Data on Oncology Pipeline
Bayer HealthCare announced that the company will present preclinical data that introduce investigational compounds for both therapy and imaging in its early oncology pipeline with unique and novel mechanisms at the American Association for Cancer Research (AACR) 102nd Annual Meeting, April 2-6, 2011, in Orlando, FL.
Emergence of hybrid PET-MRI: first clinical experience
Whole-body hybrid PET-MR scanners are emerging on the market and are expected to have a significant impact in diagnostic imaging particularly in oncology applications and also in other clinical domains, such as cardiology, inflammatory and infectious disease, as well as in neurological applications.
Biomarkers - the hallmark of personalised medicine
"One size fits all" – the phrase is a fact of life in terms of the drugs available to treat cancer patients today. This solution can bear tragic results. Only 25% of cancer patients currently respond to this ‘one size’ drugs administration. In addition, 100,000 patients die annually, in the USA alone, from the side effects of those drugs. Personalised therapies that are devised to suit…
Meaningful Innovations: Ingenuity CT and Ingenuity TF PET/CT
During RSNA, Philips announced the new Philips Ingenuity CT platform, an innovative technology that will help redefine low dose imaging. The Ingenuity CT features iDose4, Philips’ next-generation iterative reconstruction technique, designed to provide equivalent diagnostic image quality at up to 80 percent less dose; improve spatial resolution by up to 35 percent with up to 50 percent less…
New diagnostic tools win the hearts of cardiologists
During the 2010 ESC meeting, held in Stockholm, new guidelines for myocardial revascularisation were handed down by a prestigious Task Force made up of representatives of both the ESC and the European Association of Cardio-Thoracic Surgeons (EACTS).
CT and PET - Improving radiation therapy planning
When planning radiotherapy the combination of positron emission tomography (PET) and Computed tomography (CT) can provide a better outcome than CT alone. Michael Krassnitzer asked Terri Bresenham MSc BSc, Vice President for Molecular Imaging at GE Healthcare, for her views on the value of PET/CT, the new EANM guidelines, novel tracers and the future of other hybrid imaging technologies.
Alcyone Technology
Cardiologist, nuclear medicine specialist and researcher Dr Alessia Gimelli works for the Fondazione Toscana Gabriele Monasterio, National Research Council in Pisa, Italy. For the past year she has used Discovery NM 530c, GE’s latest Nuclear Cardiology platform, featuring an innovative CZT collimation technology called Alcyone Technology.
The economic value of PET-CT - a scenario-based analysis
PET/CT is an established clinical tool especially for cancer-related diagnosis. This involves both initial diagnosis and follow-up examinations. There are other procedures, like CT/MRT, bone scan, or mediastinoscopy, all of which are also costly. Given the fact that PET/CT is widely used anyway, the question arises whether it is medically responsible and financially favourable to focus solely on…